UK markets closed

Utah Medical Products, Inc. (UTMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.29+1.17 (+1.74%)
At close: 04:00PM EDT
68.29 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
16,377
16,635
16,473
14,788
10,798
-
Depreciation & amortisation
7,214
6,368
7,082
7,284
7,209
-
Deferred income taxes
-863
-681
-395
-53
-19
-
Stock-based compensation
254
225
183
166
160
-
Change in working capital
-371
-233
-2,226
-1,006
1,993
-
Accounts receivable
-
2,270
-511
-1,088
617
-
Inventory
685
-670
-2,353
-485
924
-
Accounts payable
-33
-456
464
-23
-308
-
Other working capital
20,024
21,642
20,329
20,651
19,277
-
Net cash provided by operating activities
20,642
22,281
21,147
21,203
20,137
-
Cash flows from investing activities
Investments in property, plant and equipment
-618
-639
-818
-552
-860
-
Sales/maturities of investments
-
-
-
-
0
0
Net cash used for investing activities
-591
-639
-818
-552
-860
-
Cash flows from financing activities
Common stock repurchased
-2,990
0
-2,495
0
-6,976
-
Dividends paid
-4,301
-4,282
-3,163
-11,465
-4,116
-
Net cash used provided by (used for) financing activities
-7,099
-4,165
-5,484
-10,905
-10,734
-
Net change in cash
12,896
17,816
14,078
9,384
8,803
-
Cash at beginning of period
80,912
75,052
60,974
51,590
42,787
-
Cash at end of period
93,864
92,868
75,052
60,974
51,590
-
Free cash flow
Operating cash flow
20,642
22,281
21,147
21,203
20,137
-
Capital expenditure
-618
-639
-818
-552
-860
-
Free cash flow
20,024
21,642
20,329
20,651
19,277
-